Allogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After First-line Therapy
Clinical trial NCT05675319 · TERMINATED
Trial details
- NCT number
- NCT05675319
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-03
- Primary completion
- 2025-03-14
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.